Introduction: The gold standard to assess the presence and severity of portal
A c c e p t e d M a n u s c r i p t
1) Introduction
Portal hypertension (PH) is a clinical syndrome characterised by a combination of increased resistance to blood flow in the portal venous system and/or its tributaries and endothelial dysfunction. Cirrhosis is the most common cause of intrahepatic sinusoidal PH.PHin cirrhosisdevelops as a consequence of structural changes of liver parenchyma due to inflammation, collagen deposition, nodule formation and vascular occlusion/remodelling. This "static" component causes the initial vascular modifications responsible of increasing portal pressure. Nevertheless about 1/3 is caused by a functional "dynamic" component [1, 2] . Porto-systemic collaterals develop as a consequence of the high pressure in the portal vein. However, even when portal blood flow is entirely diverted through collaterals, PH persists because of a concomitant increase in portal venous inflow, which in turn is caused by splanchnic vasodilatation [3] . This mechanism leads to further and progressive increase in PHthe relevance of which derives from its complications: formation of oesophageal or gastric varices, variceal bleeding, ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, porto-pulmonary hypertension, hepatic encephalopathy, portal hypertensive gastropathy, enteropathy and altered metabolism of endo-and xenobiotics normally metabolised by the liver [4] . The most important collaterals are gastro-esophageal varices since they represent a "marker" of PHon routine endoscopy screening and because they potentially can rupture leading to life threatening bleeding.
The gold standard to assess the presence and severity of PHremains the hepatic venous pressure gradient (HVPG), however the recent development of non-invasive assessment using elastography techniques offers valuable alternatives. In this review, we discuss the diagnostic accuracy and utility of such techniques in patients A c c e p t e d M a n u s c r i p t with established chronic liver disease. The use of these techniques in non-cirrhotic portal hypertension is outside the scope of this review.
2) Assessment of pH a) HVPG and endoscopy
Gastroscopy as a screening test for varices is routinely offered once the diagnosis of cirrhosis is confirmed because of its excellent diagnostic accuracy and potential therapeutic approach. Once the presence of gastro-esophageal varices is confirmed, medical or endoscopic treatment and subsequent follow up istailored depending on the size of varices, presence of wale marks and severity of underlying liver disease that determine the risk of bleeding [5, 6] . However, although endoscopy is obviously an important procedure to be carried out because of both diagnostic and therapeutic applications, the most important diagnostic investigation for PH is the HVPG measurement. The relationship between wedge and free hepatic venous pressure is able to provide important clues on the underlying site of resistance and hence allow an appropriate diagnosis of what is causing the increase in portal pressure.
Moreover, HVPG is directly proportional to the severity of PHin cirrhosis and therefore, it is considered the most important predictor of clinical outcome in chronic liver disease [7] [8] [9] [10] [11] . An HVPG of ≥10 mmHg defines clinically significant PH (CSPH) because is independently associated with an increased risk of decompensation [12] and development of hepatocellular carcinoma (HCC) [13] .
b) Elastography
Over the last years, the assessment of liver disease has improved substantiallydue to theintroduction of elastography. The possibility toestimate liver fibrosis and indirectly the severity of PH [14] by measuring liver stiffness (LS) has changed patient management; liver elastography is now routinely used in the clinical evaluation of A c c e p t e d M a n u s c r i p t patients with chronic liver disease [15, 16] .The use of elastography in clinical practice is based on the rationale that an applied force to a certain tissue will induce a parenchymal displacement,the entity of which is related to the tissue characteristics and properties. By measuring the speed of displacement, elastography enables to measure the parenchymal biomechanical properties that in liver disease are modified as a consequence of collagen deposition. Although the presence of fibrosis is the main determinant of increased stiffness, "confounding" factors might contribute or might even drive independently LS by increasing intrahepatic pressure (cholestasis, congestion, inflammation, food intake).
The rationale that brought to use LS measurement as an expression of PH is based on the fact that LS depends on the amount of collagen and therefore the mechanical "static"component of portal pressure. With the progression of liver disease, extrahepatic factors contribute to further increase in portal pressure. These are mainly vasoactive molecules that act by inducing intra-hepatic vasoconstriction and splanchnic vasodilation hence increasing portal pressure independently from the amount of collagen deposition. Therefore, as PH becomes more severe, the correlation between LS and HVPG is lost, as demonstrated by Vizzuti, et al. [17] , because the factors which contribute to the further increase in portal pressure go beyond the amount of fibrosis. In such cases, the measurement of spleen stiffness (SS) seems to be a more reliable marker of PH as well as predictor of hepatic decompensation. The portal vein receives blood from the splenic vein, hence any increase in portal pressure is theoretically transmitted to the spleen with a subsequent increase in intrasplenic pressure and related increased stiffness. Even though these results are encouraging, the heterogeneity of the studied populations, the relatively small number of available data and the lack of prospective studies with predefined cut-offs represent important limitation factors in terms of overall accuracy.
Among pSWE techniques, acoustic radiation force imaging (ARFI) has been widely used. Although ARFI represents a valid tool to diagnose liver cirrhosis in comparison to TE, there is only one study that evaluated the usefulness of ARFI elastography as a predictor of CSPHin 78 patients who underwent HVPG measurement [38] . The LS values were significantly higher in CSPH, with a high diagnostic performance of ARFI (AUC 0.93). However, even in this study the population was very heterogeneous in terms of aetiology, hence raising concerns on its reliability and application in clinical practice on a larger scale. [28] . However, in the latter the authors had to use rule-in and rule-out cut-off values to get a better sensitivity and specificity, with a widerange of unclassified patients. TE-SS had a poor diagnostic performance in the study of Elkrief, et al. [40] . This discrepancy may be explained by the presence of a high number of patients with decompensated liver disease and more severe PH in the population enrolled in this studywith respect to those of Zykus and Colecchia (ChildPugh C44%, 0.9% and 0%, respectively; median HVPG 17 mmHg, 14 and 12 mmHg, respectively).
It is important to mention that the number of non-reliable/failed SS assessments with TE is higher compared to those of LS. This is due to technical issuesmainly caused bysmall sizedspleens and represents an important limitation. In addition, a conventional ultrasound device is usually needed to locate the spleen.
There is only one study that evaluated the diagnostic performance of ARFI in patients who underwent an invasive measurement of portal pressure [38] .
The performance of SS using ARFI in assessing both SPH and CSPH was better than TE in this study that included a significant proportion of patients with A c c e p t e d M a n u s c r i p t decompensated liver disease and high HVPG values (Child-Pugh C 18%, median HVPG 18 mmHg). Importantly, no SS assessment failureswere reported. This is due to the fact that ARFI is an elastographic technique integrated in an ultrasound system, which allows scanperformance even in patients with high BMI, ascites or a small spleen.
Data about the diagnostic performance of SSI were controversial in two studies with heterogeneous populations regarding the severity of liver disease [40] . Similarly to ARFI, SSI is better than TE in measuring SS. Although the use of rule-in and rule-out cut-off values results in better diagnostic performance, the number of patients in the unclassified range is high (41%) [42] No data are available regarding the predictive value of ElastPQ techniques for PH measured by HVPG.
4) Elastography for the assessment of oesophageal varices (EV) a. Liver Stiffness
Many studies (Table 3) 
b. Spleen Stiffness
TE-SS alone or in combination with TE-LS and/or other parameters (i.e. laboratory, spleen size) represents a promising tool for predicting EV in patients with liver cirrhosis. Moreover, in some studies (Table 5 ) the diagnostic performance seems to be better than that of TE-LS. However, data regarding the strength of performance and cut-offsvary depending on the underlying aetiology and the Child Pugh stage of the enrolled patients.
Although the data collected so far in this setting showed that TE is promising, the percentage of failures is higher when it is performed on the spleen compared to the liver, as already mentioned. Moreover, the upper limit cut-off value of 75 kPa In a recent published prospective multicentre study, Jansen demonstrated that the diagnostic performance in detecting CSPH improved by combining LS and SS. Using a LS cut-off value of 38 kPa and SS cut-off value of 27.9 kPa, a total of 91.6% of 158 patients were correctly classified with a sensitivity of 98.3% and specificity of 83.9% [42, 63] . This needs to be further validated in independent cohorts.
5) Changes in elastography under non-selective betablockers and after tips
Few papers have been published so far regarding the influence of non-selective beta-blockers (NSBBs) treatment on LS and SS. 
7) Expert commentary
Tissue stiffness is a biomechanical measurement that has become crucial for the clinical management of patients with chronic liver disease by providing predictive information not only on the severity of fibrosis, but also on PHand the risk of clinical SS is an extremely promising extension of the use of elastography for the noninvasive assessment of PH. Although there is limited data compared to LS, SS seems able to overcome the limitations of confounding factors that affect liver parenchyma and also to be a more objective marker of PH regardless of the underlying cause. In fact, if PH is typically characterised by increased resistance to portal flow and this reflects in increased intra-splenic pressure, targeting the latter should provide more accurate information for higher values of portal pressure. The available data is very encouraging in this respect, also because by measuring SS it is potentially possible to predict the presence of CSPH in patients with pre-hepatic PH, idiopathic PH and pre-sinusoidal PH where HVPG is misleading.
8) Five-year view
Although the recent EFSUMB recommendations for non-invasive assessment of PH provide some guidance, this cannot be applied indiscriminately. Currently, the target of elastography evaluation is the exclusion of large varices rather than the diagnosis ofthe severity of PH. Large cohort studies including populations differentiated by aetiology and sub-grouped according to severity of liver disease are warranted to establish reliable LS cut-off values for the prediction of CSPH, its severity, as well as Moreover in PSC the increased LS might be due to cholestasis rather than fibrosis and there is no predictor of PH in these two conditions. SS measurements are likely to provide these answers and overcome the limitations of LS by information on intrasplenic pressure. Nevertheless further standardisation of the technique is required and we expect over the next few years dedicated software that will improve its performance. Moreover the liver structural modifications accompanied by the splanchnic vascular changes that occur in liver disease suggest that the most accurate information on the diagnosis and severity of PH is provided by the coupled assessment of liver and spleen stiffness. Such algorithms are still awaited, but hopefully will be standardized in the next five years.
9) Key issues
• Portal hypertension represents a common complication of liver cirrhosis and it is the main driver of hepatic decompensation.
• HVPG and upper-endoscopy represent the gold standard techniques to assess the presence of clinical significant portal hypertension and gastrooesophageal varices, respectively.
• A c c e p t e d M a n u s c r i p t sensitivity, specificity and cut-off values, probably due to the variability of the studied populations.
• The Baveno VI and expanded Baveno VI criteria can be used to save unnecessary endoscopies for varices detection in patients with compensated advanced chronic liver disease since they have a very high negative predictive value for varices needing treatment.
• Algorithms including both liver and spleen stiffness have a better diagnostic performance in ruling-in and out clinically significant portal hypertension, minimizing the number of misclassified patients.
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